Skin treatment composition and method

ABSTRACT

Skin treatment compositions are provided which inhibit generation of free radicals in the skin and which include 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, 6-ethoxy-1,2-dihydro-2,2,4-trimethyl quinoline or mixture thereof, and optionally a stabilizer for the 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid which is monoethanolamine sulfite or sodium bisulfite.

RELATED APPLICATIONS

This application is a continuation-in-part of application Ser. No.840,177, now U.S. Pat. No. 4,742,066, filed Mar. 17, 1986.

FIELD OF THE INVENTION

The present invention relates to improved skin treatment compositionsincluding cosmetics which have improved skin penetrating properties andinhibit generation of free radicals in the skin which may form uponexposure to ultraviolet radiation or air pollutants, to a method forcontrolling free radical formation on the skin by applying such skintreatment composition to the skin, and to a method of stabilizingVitamin E-like preparations for use in the above compositions.

BACKGROUND OF THE INVENTION

Free radical formation plays a destructive role in biological processesof living things, Pryor, W. A., Free Radicals in Biological Systems,Scientific American, Vol. 223, No. 2, pp. 70-83, August 1970, Pryor, W.A., Free Radical Pathology, Chemical and Engineering News, June 7, 1971,p. 34ff, and Harman, D., The Aging Process, Proc. Natl. Acad. Sci.,U.S.A., Vol. 78, No. 11, pp 7124-7128, Nov. 1981. It has been found thatexposure of human skin to ultraviolet radiation and air pollutants couldresult in the generation of free radicals in the exposed skin whichcould lead to premature aging of such skin. Accordingly, a topical skintreatment composition which could inhibit generation or deactivation offree radicals in the skin resulting from exposure to ultravioletradiation and/or air pollutants would indeed be most a welcome additionto the skin treatment field.

Vitamin E (α-tocopherol) which has the structure ##STR1## has beenemployed to inhibit oxidation of oils and fats in foods, cosmeticpreparations and drugs and for its soothing and antiinflammatoryproperties. It has also been found that a number of 6-hydroxychromans,including rac-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid(Trolox C) which has the structure ##STR2## exhibit antioxidant activity(Scott et al, "Antioxidant Properties of6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, Cosmetics andToiletries, Vol. 91, Nov. 1976).

DESCRIPTION OF THE INVENTION

This invention is directed to improved skin treatment compositions,including cosmetic preparations, for inhibiting generation ordeactivating free radicals in the skin and which includes at least onefree radical inhibitor or deactivator which is6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox C) or6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline (ethoxyquin) or mixturesthereof in an amount within the range of from about 0.01 to about 5% byweight and preferably from about 0.10 to about 0.5% by weight of thecomposition. Trolox is a trademark of Hoffmann-LaRoche.

Furthermore, in accordance with the present invention, it hasunexpectedly been found that the Trolox C compound not only hasantioxidant activity and antiinflammatory activity similar to that ofVitamin E, but that Trolox C by itself or formulated in skin treatmentcompositions in accordance with the present invention, has skinpenetrating capacity which is surprisingly superior to that of VitaminE. Accordingly, the skin treatment compositions of the invention containa more skin penetrating form and thus a faster acting form of Vitamin E,that is Trolox C, than heretofore known.

In addition, there is provided a more stable form of Trolox C and amethod for stabilizing Trolox C by employing Trolox C together with astabilizer therefor, namely, sodium bisulfite or monoethanolaminesulfite and a method for stabilizing Trolox C against discoloration andoxidation by employing such stabilizer in composition with Trolox C.

A stabilized form of Trolox C in accordance with the present inventionwill comprise a stabilized composition containing from about 0.01 toabout 5% Trolox C and preferably from about 0.1 to about 0.5% by weightTrolox C; and if necessary for solubility, an equivalent weight ofstrong base such as potassium hydroxide, sodium hydroxide, or lithiumhydroxide (in an amount within the range of from about 0.02 to about0.1% by weight) or organic amine, such as triethanolamine (in an amountwithin the range of from about 0.06 to about 0.3% by weight), from about50 to about 90% and preferably from about 60 to aobut 80% by weightwater; from about 0.05 to about 2% and preferably from about 0.1 toabout 1% by weight preservative; and from about 0.02 to about 0.05% andpreferably from about 0.05 to about 0.1% by weight stabilizer which issodium bisulfite or monoethanolamine sulfite which inhibitsdiscoloration and oxidation of the Trolox C, all of the above % byweight being based on the weight of said stabilized composition.

In the above composition, the Trolox C will be employed in a molar ratioto the stabilizer of within the range of from about 10:1 to about 0.5:1and preferably from about 5:1 to about 1:1.

In addition, depending upon the form that the skin treatment compositionof the invention will take, for example, moisturizing composition, skintoner, skin cleanser, night cream, day lotion, shampoo or cosmeticpreparation, it will also include water, at least one preservative,preferably, at least one humectant, at least one emulsifier and/orthickener, and optionally may contain one or more chelating agents, oneor more gelling agents, one or more emollients, one or more solvents forthe free radical inhibitor or deactivator, one or more sun screenagents, and/or one more fragrances and/or one or more coloring agents.

The skin treatment composition of the invention is preferably onail-in-water type emulsion since this type of emulsion affords bettercosmetic feel to the product. However, the product could also beformulated as a water-in-oil emulsion, cream base, oil base oraqueous/alcoholic or glycol solution, microemulsion or liposome.Depending upon the choice of ingredients, the formulation has asemi-solid cream-like consistency which can be packaged in a plasticsqueeze tube, a lotion type consistency which can be packaged in aplastic squeeze container, an ointment-type consistency which can bepackaged in a squeeze type container or a liquid consistency which maybe packaged in a bottle. The container can include a flow-type cap orpump-type dispenser.

In addition, in accordance with the present invention, a method isprovided for controlling free radical formation in skin, which includesthe step of applying to the skin an effective amount of a skin treatmentcomposition as disclosed herein.

The skin treatment composition of the invention may take the form of alotion, cream, liquid, or ointment.

In general, regardless of the form of the skin treatment composition ofthe invention, it will include from about 0.01 to about 5%, andpreferably from about 0.1 to about 0.5% by weight of the free radicalinhibitor or deactivator, and, if necessary for solubility, anequivalent weight of caustic hydroxide, such as potassium hydroxide, (inan amount within the range of from about 0.02 to about 0.01% by weight)or organic amine, such as triethanolamine (in an amount within the rangeof from about 0.06 to about 0.3% by weight), from about 50 to about 90%and preferably from about 60 to about 80% by weight water, from about 1to about 25% and preferably from about 5 to about 10% by weight of oneor more humectants, from about 1 to about 10% and preferably from about1 to about 5% by weight of one or more emulsifiers when the compositionis a cream, lotion or ointment, from about 0.05 to about 4% andpreferably from about 0.05 to about 3% by weight of one or morethickeners or gelling agents where the composition is a cream, lotion orointment, optionally from about 0.001 to about 2% and preferably fromabout 0.01 to about 1% by weight of an enzyme or modified enzyme toenhance free radical inhibitor acitivty, optionally from about 0.01 toabout 5% and preferably from about 1 to about 3% by weight of one ormore adjuvant oxygen deactivators, from about 0.5 to about 2% andpreferably from about 0.1% to about 1% by weight of one or morepreservatives, and the following optional ingredients: from about 0.01to about 0.5% and preferably from about 0.05 to about 0.1% by weight ofone or more chelating agents, from about 1 to about 30% and preferablyfrom about 1 to about 10% by weight of one or more emollients when thecomposition is a cream, lotion or ointment, from about 1 to about 50%and preferably from about 5 to about 10% by weight of one or moresolvents for the free radical inhibitor or deactivator, from about 1 toabout 15% and preferably from about 1.5 to about 10% by weight of one ormore sun screen agents, less than about 1% by weight of one or morefragrances and/or less than about 1% by weight of one or more colorants.In addition, the skin treatment composition of the invention may alsooptionally include various other conventional ingredients normallyemployed in skin conditioning or moisturizing compositions or sunscreencompositions such as skin conditioning agents, moisturizers, waxes,polymers or other active ingredients.

Where the free radical inhibitor employed is Trolox C, the compositionof the invention may optionally contain from about 0.2 to about 0.5% andpreferably from about 0.05 to about 0.1% by weight stabilizer for theTrolox C.

The skin treatment composition of the invention may optionally containenzymes of modified (PEG-, dextran PVP) enzymes to enhance acitivity;for example, polyethylene glycol modified superoxide dismutase orcatalase. The composition may also optionally contain adjuvants todeactivate singlet oxygen or other active chemicals including but notlimited to carotenoids (beta carotene, canthaxanthin, bixin), sulfurcompounds (glutathione, cysteine, thioglycerol,dilaurylthiodiproprionate) or aromatic hydroxy or quinone compounds(e.g., quercetin, curcumin, hydroquinone) or vitamins (ascorbic acid,alpha-tocopherol).

Suitable preservatives include imidazolidinyl urea (Germall 115),methylparaben (Tegosept M), quaternium-15 (N-(3-chloroallyl)hexaminiumchloride, Dowicil 200), propylparaben (Tegosept P), dimethyldimethoylhydantoin, benzyl alcohol and/or phenoxyethanol, etc., and a preferredantioxidant is a mixture of butylated hydroxyanisole, propylene glycol,propyl gallate and citric acid (Tenox 2). The formulation willpreferably contain the antioxidant mixture and one or more of thepreservatives or any other preservatives and antioxidants approved forcosmetic use.

Where the skin treatment composition of the invention is in the form ofa lotion, cream, or ointment, it will preferably include one or moreemulsifiers, thickeners, humectants and emollients.

Suitable emulsifiers include polyethylene glycol 20 sorbitan monolaurate(Polysorbate 20), polyethylene glycol 5 soya sterol, sorbitantristearate, sorbitan trioleate, glyceryl monopalmitate, diethanolaminecetyl phosphate, glyceryl monopalmitate, glyceryl monostearate,polyethylene glycol 100 stearate, polyethylene glycol 20 stearyl ether(Brij 78, Steareth 20), polyethylene glycol ether of lauryl alcohol(Laureth 23), polysorbate 80 (Tween 80), lecithin, etc. The formulationwill preferably contain a mixture of two or more of these emulsifiers orothers which are approved for cosmetic use.

Thickeners or gelling agents which may be present include Carbopol 934or Carbomer 940 which is a hydrophilic acrylic polymer cross-linked witha polyfunctional agent and employed with an organic or inorganic base,preferably triethanolamine. Other examples of thickeners which may beemployed herein include, but are not limited to, stearic acid, fattyalcohols, such as cetyl alcohol, stearyl alcohol, magnesium aluminumsilicate, stearoxydimethicone, hydroxyethyl cellulose, propylene glycolmonostearate, hydroxypropyl cellulose, carboxymethyl cellulose, xanthangum, myristyl stearate, or cetyl stearate.

Suitable emollients or oleaginous materials include mineral oil,petrolatum, glyceryl monooleate, myristyl alcohol, isopropyl palmitate,avocado oil, squalane, octyl palmitate, cocoa butter, sesame oil,propylene glycol dicaprylate/dicaprate, isopropyl myristate, diisopropyldimerate (that is, the diester of isopropyl alcohol and dimer acid),dimethicone, stearoxydimethicone, and the like. The formulation willpreferably contain a mixture of several of these emollients or otherswhich are approved for cosmetic use.

Skin conditioning agents which may optionally be present in thecomposition of the invention include allantoin, d- or dl-panthenol,hydrolyzed animal protein and the like. Such conditioning agents may bepresent in an amount within the range of from about 0.01 to about 10%and preferably from about 0.05 to about 2% by weight and optimally fromabout 0.1 to about 2% by weight depending upon the ultimate use of theskin preparation.

Solvents for the free radical inhibitors which may be present includepolyethylene glycol wax (such as Carbowax 400), propylene glycol orethanol (for Trolox C) and/or an equivalent weight of strong base suchas potassium hydroxide or organic amine such as triethanolamine (basedon M.W. of Trolox C of 250.3), and mineral oil, vegetable oils,synthetic esters for ethoxyquin.

Chelating agents for sequestering metal ions in aqueous solution whichmay be present herein include disodium ethylenediamine tetraacetic acid,EDTA, tetrasodium EDTA, or citric acid.

As indicated, the skin treatment compositions of the invention mayinclude one or more known ultraviolet absorbing agents, preferably atleast one compound which absorbs in the UV-B region (wavelength 290 to320 nanometers) and optionally one or more other compounds which absorbin the UV-A region (wavelength 320 to 400 nanometers). The total amountof UV absorbing agents included within the formulation will be fromabout 2% to about 15% by weight, which amount will determine whether itis a sunscreen or sunblock.

Suitable UV-A absorbing agents which may be employed include2-(2'-hydroxy-5'-methylphenyl)benzo-triazole (Tinuvin P);2-(2'-hydroxy-5'-t-octylphenyl)benzotriazole (Spectra-Sorb UV 5411);2,4-dihydroxybenzophenone (Uvinul 400); 2-hydroxy-4-methoxybenzophenone(oxybenzone, Spectra-Sorb UV9, Uvinul M-40);2,2',4,4'-tetrahydroxybenzophenone (Uvinul D50);2,2'-dihydroxy-4,4'-dimethoxybenzophenone (Uvinul D49);2,2'-dihydroxy-4-methoxybenzophenone (dioxybenzone, Spectra-Sorb UV24);2-ethylhexyl-4-phenyl-benzophenone carbonate (Eusolex 3573);2-hydroxy-4-methoxy-4'-methylbenzophenone (mexenone, Uvistat 2211);2-hydroxy-4-(n-octyloxy)benzophenone (octabeenzone, SpectraSorb UV531);4-phenylbenzophenone (Eusolex 3490); and2-ethylhexyl-2-cyano-3,3'-diphenylacrylate (Uvinul N539); butylmethoxydibenzoyl methane (Parsol 1789), and benzphthalide (Escalol 547).The UV-A absorbing agent or agents are present in the final product atfrom 0 to about 10% by weight of the formulation. The amount will varyaccording to the particular agent selected and whether the formulationis intended to minimize or permit tanning. Where a UV-A absorbing agentis employed, the preferred UV-A absorbing agent is2-hydroxy-4-methoxybenzophenone alone or in combination with2,2'-dihydroxy-4-methoxybenzophenone.

Suitable UV-B absorbing agents include 4-(dimethylamino)benzoic acid,ethyl ester; 4-(dimethylamino)benzoic acid, 2-ethylhexyl ester (Escalol507); 4-(dimethylamino)benzoic acid, pentyl ester (Escalol 506);glyceryl p-amino-benzoate (Excalol 106); isobutyl p-amino-benzoate(Cycloform); and isopropyl p-amino-benzoate; 2-ethylhexyl methoxycinnamate (Parsol MCX); phenylbenzimidazole sulfonic acid (Eusolex 232);homomenthyl salicylate, and ethyl hexyl salicylate. The UV-B absorbingagent or agents are present in the final product at from about 1% toabout 15% by weight of the formulation. The amount will vary accordingto the particular agent selected and degree of protection desired in thefinal product. The preferred UV-B absorbing agent is4-(dimethylamino)benzoic acid, 2-ethyl-hexyl ester (Escalol 507).

Where the skin treatment composition is in the form of a lotion, cream,or liquid, the free radical inhibitor or deactivator as well as anyother actives that may be present will be "all-in-solution" (i.e.,solubilized or emulsified) so that substantially no active ingredientcrystallizes out at room temperature.

With regard to the cream formulations of the invention where the activeingredients are to be all-in-solution, the cream will contain from about0.01 to about 5% and preferably from about 0.1 to about 0.5% by weightof the free radical inhibitor based on the weight of the entire creamformulation, and from about 1 to about 50% and preferably from about 5to about 10% by weight of solvents for the free radical inhibitor basedon the weight of the entire cream formulation. Examples of such solventsinclude Carbowax 400, propylene glycol, and/or an equivalent weight ofstrong base such as potassium hydroxide or organic amine such astriethanolamine (based on M.W. or Trolox C of 250.3) (for Trolox), andmineral oil or C₁₂ -C₁₅ alcohols benzoate (for the ethoxyquin). Theall-in-solution cream formulation will also include in the oil phase,from about 2 to about 15% and preferably from about 5 to about 10% byweight of the emulsifier-thickener based on the weight of the entirecream formulation, and from about 2 to 30% and preferably from about 3to about 15% by weight of oleaginous material or emollient based on theweight of the entire cream formulation. The oil phase may also includeone or more preservatives similar to that present in the aqueous phasedescribed below.

The aqueous phase of the all-in-solution cream formulation may contain aglycol type preservative or humectant such as propylene glycol and/or aparaben or other conventional type perservative such methyl and/orpropyl paraben, and purified water in amount within the range of fromabout 30 to about 80% by weight and preferably from about 35 to about65% by weight of the entire cream formulation.

With regard to the lotion formulation of the invention where the freeradical inhibitor is to be all-in-solution, the lotion will contain fromabout 0.01 to about 5% and preferably from about 0.1 to about 0.5% byweight of the free radical inhibitor based on the weight of the entirelotion formulation, and, if necessary, for solubility an equivalentamount of strong base such as potassium hydroxide or organic amine suchas triethanolamine. The active ingredient in the all-in-solution lotionformulation can have part of it also solubilized in the oil phase. Thelotion may contain from about 1 to 10% and preferably from about 2 toabout 5% by weight emulsifier-thickener based on the weight of theentire lotion formulation, and from about 2 to about 20% and preferablyfrom about 4 to about 10% by weight of oleaginous material or emollientbased on the weight of the entire lotion formulation. The oil phase mayalso optionally include one or more preservatives.

The aqueous phase of the all-in-solution lotion formulation may containone or more preservatives and purified water in an amount within therange of from about 60 to about 90% by weight and preferably from about70 to about 85% by weight of the entire lotion formulation.

Where the free radical inhibitor is to be employed in liquid solution,the concentration of free radical inhibitor will be in amounts rangingfrom about 0.1 to about 5% by weight together with from about 2 to about99% by weight solvent therefor and, if necessary, for solubility, astrong base or organic amine as described hereinbefore.

The ointment formulation of the invention comprises a free radicalinhibitor as described herein and an oleaginous material, and optionallya wax.

The term "ointment" or "ointment formulation" as employed hereinincludes non-aqueous formulations such as gels, ointments, lipophilicsticks, and the like.

The oleaginous material or emollient will generally be present in amountwithin the range of from about 30 to about 99% by weight, and preferablyfrom about 50 to about 90% by weight.

The ointments of the invention may include the free radical inhibitorsolubilized in both the aqueous phase and in the oil phase. Thepercentage of water in the aqueous phase may vary from about 5 to about20% of the ointment.

The ointment will contain from about 0.01 to about 5%, and preferablyfrom about 0.025 to about 0.5% by weight of the free radical inhibitorand from about 2 to about 99% by weight solvent therefor such as set outabove. The all-in-solution ointment formulation (exclusive of the geland lipophilic stick) will also include, in addition to the free radicalinhibitor from about 85 to about 99% and preferably from about 85 toabout 95% by weight of oleaginous material based on the weight of theentire formulation. The formulation may also optionally include anopacifying agent, such as titanium dioxide, serving as indicator forhomogeneity of dispersion, in an amount within the range of from about0.2 to about 1% and preferably from about 0.3 to about 0.8% by weightbased on the entire formulation. When the free radical inhibitor ismechanically dispersed in the oleaginous material, the latter may bemineral oil thickened with polyethylene as disclosed in U.S. Pat. No.2,627,938, 2,628,187, 2,628,205 and 3,733,403. The disclosures of theforegoing patents are incorporated herein by reference.

The all-in-solution ointment may simply be prepared by dissolving theactive ingredient in a solvent therefor such as propylene glycol and/orpolyethylene glycol wax (for Trolox) or C₁₂ -C₁₅ alcohol benzoate (forethoxyquin), with gentle heat not over 90° C., cooling to roomtemperature and then incorporating the same into the oleaginous materialby slow mixing until homogeneous.

The gel formulation of the invention is preferably in the form of alipophilic clear gel, and will contain from about 0.01 to about 5%, andpreferably from about 0.1 to about 0.5% by weight of the free radicalinhibitor based on the weight of the entire formulation, and from about10 to about 99% and preferably from about 50 to about 80% by weight of asolvent for the free radical inhibitor (as described above) based on theweight of the entire formulation, depending upon the solubility of theparticular inhibitor ingredient in the particular solvent employed. Thegel formulation will also include from about 30 to about 99% andpreferably from about 60 to about 85% by weight of the oleaginousmaterial. The formulation may also optionally include a surfactant, suchas Span 65 (sorbitan tristearate), as well as Span 60 (sorbitanmonostearate), Span 40 (sorbitan monopalmitate) or butylene glycoldistearate in amounts up to about 8% by weight based on the entireformulation. An antioxidant, such as butylated hydroxyanisole orbutylated hydroxytoluene may also optionally be included in amounts upto about 0.1% and preferably up to about 0.5% by weight based on theentire formulation.

In the non-aqueous gel formulation of the invention, the oleaginousmaterial includes mineral oil gelled with waxes such as high molecularweight paraffin was (Paraflint RG), mono and diglycerides of fatty acidssuch as Arlacel 186 (Atlas Co.) as well as propylene glycol isostearate(Emery 2389A) or isostearyl alcohol (Adol 66), gelled with highmolecular weight fatty acids such as Emery 865A (Emery Industries),and/or polyamide complex of hydroxystearate (Acrowax, Glyco).

The lipophilic stick of the invention may contain from about 0.01 toabout 5%, and preferably from about 0.1 to about 0.5% by weight freeradical inhibitor and from about 10 to about 80% and preferably fromabout 40 to about 60% by weight of the solvent therefor (such asdescribed above) and from about 20 to 50% and preferably from about 25to about 45% by weight oleoginous material. Oleaginous materials whichmay be employed include high melting waxes, such as carnauba wax, inamounts ranging from about 6 to about 10% and preferably about fromabout 7 to about 9%, beeswax in amount ranging from about 14 to about18% and preferably from about 15 to about 17%, as well as petrolatum inamounts ranging from about 2 to about 5% and preferably from about 3 toabout 4%, and isotearyl neo pentanoate (Ceraphyl 375, Van Dyk) inamounts ranging from about 8 to about 11% and preferably from about 9 toabout 10.5%.

In the case of ointments, lipophilic gels and sticks where theformulation is substantially free of water, the free radical inhibitorwill be dissolved in the solvent vehicle and, in part, in the oilmaterial employed.

Examples of preferred formulations in accordance with the presentinvention include, but are not limited to, the following:

    ______________________________________                                                             Range in                                                                      % by weight                                              ______________________________________                                        Cream formulation                                                             Free radical inhibitors                                                                              0.1 to 0.5                                             Stabilizer for Trolox C                                                                              0 to 0.1                                               Solvents for inhibitors (including                                                                   5 to 10                                                neutralizing bases)                                                           Emulsifiers            2 to 5                                                 Thickeners             2 to 20                                                Humectant              2 to 20                                                Chelating Agent        0.05 to 0.1                                            Water                  50 to 80                                               Preservatives          0.2 to 1                                               Lotion formulation                                                            Free radical inhibitors                                                                              0.1 to 0.5                                             Stabilizer for Trolox C                                                                              0 to 0.1                                               Solvents for inhibitors (including                                                                   5 to 10                                                neutralizing bases)                                                           Emulsifiers            1 to 5                                                 Thickeners             1 to 10                                                Humectants             2 to 10                                                Chelating Agents       0.05 to 0.1                                            Water                  60 to 90                                               Preservatives          0.2 to 1                                               Ointment formulation                                                          Free radical inhibitors                                                                              0.1 to 0.5                                             Stabilizer for Trolox C                                                                              0 to 0.1                                               Solvents for inhibitors (including                                                                   5 to 80                                                neutralizing bases)                                                           Oleagnous materials    20 to 90                                               Emulsifiers or thickeners                                                                            10 to 30                                               Solution or Liquid formulation                                                Free radical inhibitors                                                                              0.1 to 0.5                                             Stabilizer for Trolox C                                                                              0 to 0.1                                               Solvents for inhibitors (including                                                                   5 to 10                                                neutralizing bases)                                                           Water                  75 to 90                                               ______________________________________                                    

The various formulations of the invention may be prepared employingconventional procedures as outlined in the working Examples.

EXAMPLE 1

A skin treatment (moisturizer) composition in the form of a lotion ofthe following composition was prepared as described below.

    ______________________________________                                                               Parts by                                               Ingredient             Weight                                                 ______________________________________                                        Blend I                                                                       Deionized water        74.1                                                   Disodium ethylenediamine                                                                             0.05                                                   tetraacetic acid                                                              (Sequestrene Na.sub.2 - chelating agent)                                                             0.3                                                    (Carbopol 934, gellant-thickener)                                             Blend II                                                                      Propylene glycol (solvent,                                                                           5                                                      humectant                                                                     Benzyl alcohol (preservative)                                                                        0.5                                                    Methyl paraben (preservative)                                                                        0.15                                                   Blend III                                                                     PEG 5 soya sterol      2                                                      (Generol 122E5-emulsifier)                                                    PEG ether of lauryl alcohol                                                                          2                                                      (Laureth 23-emulsifier)                                                       Glyceryl monostearate (Tegin                                                                         1                                                      90, emulsifier, thickener)                                                    Cetyl alcohol (thickener)                                                                            0.5                                                    Stearic acid (thickener)                                                                             1.25                                                   Diisopropyl dimerate (diester                                                                        5                                                      of isopropyl alcohol and                                                      dimer acid-emollient)                                                         Dimethicone (Silicone 225, emollient)                                                                1                                                      Stearoxydimethicone (Silicone wax                                                                    1                                                      755-emollient-bodying agent)                                                  Propyl paraben (preservative)                                                                        0.1                                                    Butyl paraben (preservative)                                                                         0.05                                                   6-Ethoxy-1,2-dihydro-2,2,4-                                                                          0.1                                                    trimethylquinoline (Santoquin-                                                free radical inhibitor)                                                       Triethanolamine (Carbopol                                                                            0.4                                                    neutralizer)                                                                  Deionized water        0.4                                                    Blend IV                                                                      Polyethylene glycol (Carbowax                                                                        5                                                      400, humectant, solvent for                                                   Trolox)                                                                       6-Hydroxy-2,5,7,8-tetramethyl-                                                                       0.1                                                    chroman-2-carboxylic acid                                                     (Trolox C-free radical inhibitor)                                             ______________________________________                                    

Aqueous Blend I was prepared by dispersing the ingredients in thedeionized water. Blend II (prepared by simple mixing of ingredients) wasthen mixed with Blend I. The combined Blend I-II was then heated to 75°C.

Blend III was formed by simple mixing of the ingredients in a separatevessel while heating to 75° C.

Blend III (heated at 75° C.) was then added to the combined Blend I-II(also at 75° C.) with sweep mixing.

The combined Blend I-II-III was heated at 75° C. for 30 minutes, allowedto air cool to 60° C., and then Blend IV (prepared by simple mixing ofingredients) was added with sweep mixing. The resulting batch was thenallowed to air cool to 30° C. to form the moisturizer lotion formulationof the invention.

EXAMPLE 2

    ______________________________________                                        Topical Cream Moisturizer, 0.1% (all-in-solution)                             ______________________________________                                        6-Hydroxy-2,5,7,8-tetramethyl-                                                                         0.1    gm.                                           chroman-2-carboxylic acid (Trolox C)                                          (free radical inhibitor)                                                      Polyethylene glycol (Carbowax                                                                          5      gm.                                           400, solvent)                                                                 Petrolatum, U.S.P.       16.0   gm.                                           Promulgen, Type D (Cetearyl                                                                            8.0    gm.                                           alcohol & Ceteareth-20),                                                      Amerchol                                                                      Methylparaben            0.15   gm.                                           Propylparaben            0.02   gm.                                           Purified Water, sufficient to make                                                                     100.0  gm.                                           ______________________________________                                    

A solution of Trolox and polyethylene glycol is formed by gentle heatingof a mixture thereof at not over 90° C. The parabens are then dissolvedin the Trolox and polyethylene glycol solution with gentle heat, notover 90° C. Petrolatum and Promulgen D are melted together. Aftermixing, the mixture is added to the solution with thorough mixing,maintaining the temperature at 75°-80° C. Water is heated to 80° C. toform the aqueous phase which is added with vigorous agitation to the oilphase to emulsify. Agitation is continued until the temperature dropsdown to 48° C. Sufficient 50° C. water is added to make 100 gm. Mixingis continued at a slow rate to congeal the mixture, until thetemperature drops to 30°C.

EXAMPLE3

    ______________________________________                                        Ointment, 0.1% (all-in solution)                                              ______________________________________                                        6-Ethoxy-1,2-dihydro-2,2,4-                                                                            0.1   gm.                                            trimethylquinoline (Santoquin-                                                free radical inhibitor)                                                       (Solvent) C.sub.12 -C.sub.15 alcohols                                         benzoate                                                                      Titanium Dioxide         5     gm.                                            Plastibase 50 W (mineral oil)                                                                          0.5   gm.                                            (95%) gelled with polyethylene                                                (5%) sufficient to make 100.0 gm.                                             ______________________________________                                    

The free radical inhibitor is dissolved with gentle heat not over 90° C.The solution is cooled to room temperature and titanium dioxide isdispersed homogeneously into the oil. The suspension is incorporatedinto the Plastibase by slow rate of mixing until homogeneous to form theointment.

EXAMPLE 4

    ______________________________________                                        Lipophilic Gel, 0.1% (all in solution)                                        ______________________________________                                        6-Hydroxy-2,5,7,8-tetramethyl-                                                                        0.1     gm.                                           chroman-2-carboxylic acid (Trolox)                                            (free radical inhibitor)                                                      Polyethylene glycol     1       gm.                                           (carbowax 400)                                                                Mineral Oil, U.S.P.     80.375  gm.                                           Parflint RG (High melting                                                                             6.0     gm.                                           paraffin wax), Moore and Munger                                               Span 65 (Sorbitan tristearate, ICI)                                                                   3.6     gm.                                           ______________________________________                                    

Paraflint RG and Span 65 are melted and heated to 100° C.) The moltenmixture is incorporated in hot (100° C.) mineral oil and mixed well. Thetemperature of the oil is quickly brought to 50° C. to form a gel.

The free radical inhibitor is dissolved in the polyethylene glycol bygentle heat, the oil is cooled to room temperature and then isincorporated in the gel homogeneously.

EXAMPLE 5

A sunscreen oil-in-water formulation in the form of a lotion having thefollowing composition is prepared as described below.

    ______________________________________                                        Ingredient          Parts by Weight                                           ______________________________________                                        Blend I                                                                       Deionized water     68                                                        Magnesium aluminum silicate                                                                       0.5                                                       (Veegum R, thickener)                                                         Triethanolamine (99%)                                                                             0.1                                                       Blend II                                                                      Polyethylene glycol 400                                                                           5                                                         (humectant)                                                                   Methyl paraben      0.2                                                       (Tegosept M, preservative)                                                    Xanthan gum (Keltol F,                                                                            0.2                                                       thickener)                                                                    6-Hydroxy-2,5,7,8-tetra-                                                                          0.1                                                       methylchroman-2-carboxylic                                                    acid (Trolox C-free radical                                                   inhibitor)                                                                    Blend III                                                                     Polyethylene glycol stearyl                                                                       1                                                         ether (Brij 78, emulsifier)                                                   Cetyl alcohol       0.5                                                       (thickener, emollient)                                                        Stearic acid (thickener)                                                                          2                                                         Propylparaben       0.1                                                       (Tegosept P, preservative)                                                    Butylparaben        0.1                                                       (Tegosept B, preservative)                                                    Polyethylene glycol 100                                                                           2                                                         stearate and glycerol                                                         monostearate (1:1) (Arlacel                                                   165, emulsifier)                                                              C.sub.12 -C.sub.15 alcohol benzoate                                                               2                                                         (Finsolv TN, emollient)                                                       Polyethylene glycol 5 soya                                                                        0.5                                                       sterol (Generol 122 E5,                                                       emollient, emulsifier)                                                        Cetearyl octanoate  4                                                         (Purcellin oil, emollient)                                                    4-(Dimethylamino)benzoic acid,                                                                    2                                                         2-ethylhexyl ester (Escalol 507,                                              sunscreen, UV-B)                                                              Blend IV                                                                      Deionized water     10                                                        Troxerutin (tri(hydroxy-                                                                          1                                                         ethyl)rutoside) (sun                                                          protection                                                                    Blend V                                                                       Chloroallyl methenamine                                                                           0.1                                                       chloride (Dowicil 200,                                                        preservative)                                                                 Deionized water     0.5                                                       ______________________________________                                    

Aqueous Blend I is prepared by mixing the thickener ingredients in thedeionized water. Blend II, prepared by simple mixing of ingredients, isthen mixed with Blend I. The combined Blends I-II is then heated to 75°C.

Blend III is formed by simple mixing of the ingredients in a separatevessel while heating at 75° C.

Blend III (heated at 75° C.) is then added to the combined Blend I-II(also at 75° C.) with sweep mixing.

The combined Blend I-II-III was heated at 75° C. for 30 minutes, allowedto air cool to 60° C. and then Blends IV and V each formed by simplemixing of ingredients are separately added with sweep mixing.

The resulting batch is then allowed to air cool to 30° C. to form thesunscreen formulation of the invention.

EXAMPLE 6

A protective daytime lotion/moisturizer having the following compositionis prepared as described below.

    ______________________________________                                        Ingredient             Parts by Weight                                        ______________________________________                                        Mix A                                                                         Deionized water (diluent)                                                                            74                                                     Magnesium aluminum silicate                                                                          0.5                                                    (thickener stabilizer)                                                        dl-Panthenol (skin protecting                                                                        1                                                      agent)                                                                        Monoethanolamine sulfite                                                                             0.1                                                    (stabilizer)                                                                  Mix B                                                                         Troxerutin             1                                                      Octyl dimethyl p-aminobenzoic acid                                                                   2                                                      (sunscreen)                                                                   Diisopropyl dimerate (emollient oil)                                                                 4                                                      Propylene glycol dicaprylate/-                                                                       8                                                      dicaprate (emollient oil)                                                     Propyl paraben (preservative)                                                                        0.1                                                    Stearic acid (opacifier, bodying                                                                     3                                                      agent)                                                                        Brij 78 (Steareth 20) (emulsifier)                                                                   2                                                      Glyceryl stearate and PEG 100                                                                        3                                                      stearate (emulsifier, thickener)                                              Mix C                                                                         Carbowax 400 (PEG 8) (humectant)                                                                     3                                                      Xanthan gum (thickener, stabilizer)                                                                  0.1                                                    Methyl paraben (preservative)                                                                        0.2                                                    6-Hydroxy-2,5,7,8-tetramethylchroman-                                                                0.3                                                    2-carboxylic acid (Trolox C-free                                              radical inhibitor)                                                            Triethanolamine (99%)  0.2                                                    Mix D                                                                         Glydant (dimethyldimethoyl hydantoin)                                                                0.4                                                    (preservative)                                                                ______________________________________                                    

Each of Mixes A and B are heated to 75° C. and Mix B is added to Mix Awith propeller type mixing while maintaining the 75° C. temperature for1 hour. The resulting mixture is cooled to 65° C. and Mix C is added.The mixture is then cooled to 50° C. and Mix D is added. Cooling iscontinued to 30° C. to form the protective daytime lotion/moisturizer ofthe invention which is found to have improved feel and barrierproperties, is naturally compatible with the skin and has improved skinpenetrability.

EXAMPLE 7

A soothing facial make-up having the following composition is preparedas described below.

    ______________________________________                                        Ingredient             Parts by Weight                                        ______________________________________                                        Phase A                                                                       Deionized water        48                                                     Veegum R (magnesium aluminum                                                                         1                                                      silicate) (thickener)                                                         Phase B                                                                       Kaolin 2749 (skin protectant)                                                                        4                                                      Umber 1985R            0.5                                                    Russet C33-2527        0.3                                                    Yellow 2576            1                                                      Blue 3516              0.01                                                   Phase C                                                                       TiO.sub.2 water dispersable                                                                          10                                                     (90% TiO.sub.2, 10% Talc)                                                     Phase D                                                                       Alcolec 413S (lecithin and Poly-                                                                     1                                                      sorbate 20 and sorbitan laurate                                               and propylene glycol stearate and                                             propylene glycol laurate)                                                     Phase E                                                                       Deionized water        1                                                      dl-Panthenol (skin protectant)                                                                       0.5                                                    Phase F                                                                       Carbowax 400 (humectant)                                                                             4.5                                                    Tegosept P (propyl paraben)                                                                          0.2                                                    (preservatives)                                                               Keltrol F (xanthan gum)                                                                              0.2                                                    (thickener)                                                                   6-Hydroxy-2,5,7,8-tetramethylchroman-                                                                0.5                                                    2-carboxylic acid (Trolox C-free                                              radical inhibitor)                                                            Phase G                                                                       Deionized water        2                                                      Triethanolamine (96%) (emulsifier)                                                                   1                                                      Monoethanol amine sulfite                                                                            0.2                                                    (stabilizer)                                                                  Phase H                                                                       Tegosept P (propyl paraben)                                                                          0.1                                                    (preservative)                                                                Butoben (butyl paraben)                                                                              0.1                                                    (preservative)                                                                Klearol (mineral oil) (emollient)                                                                    5                                                      Miglyol 840 (propylene glycol                                                                        6                                                      dicaprylate/tricaprate) (emollient)                                           Stearic acid (emulsifier, thickener)                                                                 3.5                                                    Tegin 515 (glyceryl monostearate)                                                                    2.5                                                    (auxiliary emulsifier, thickener)                                             Escalol 507 (octyl dimethyl p-amino                                                                  2.5                                                    benzoic acid) (sunscreen)                                                     Uvinol M-40 (benzophenone 3)                                                                         0.5                                                    (sunscreen)                                                                   Troxerutin             1                                                      Silicone 225 (emollient)                                                                             1.5                                                    Avocado oil (emollient)                                                                              0.5                                                    PEG-6000 distearate (emulsifier                                                                      0.2                                                    thickener)                                                                    Vitamin E, dl alpha-tocopherol                                                                       0.1                                                    (antioxidant)                                                                 Phase I                                                                       Deionized water        0.75                                                   Germall 115 (preservative)                                                                           0.25                                                   Phase J                                                                       Carbowax 400 (humectant)                                                                             0.5                                                    Exaltolide (pentadecalactone)                                                                        0.5                                                    (odor masking agent)                                                          ______________________________________                                    

The Phase A ingredients are homomixed for 15 minutes. Thereafter, a mixof the Phase B ingredients are added to the Phase A mixture with mixingfor 1 hour.

Phase C is then mixed with Phase AB for 1/2 hour under slow speedmixing. Phase D is then added to the aforementioned mix with mixing for1/2 hour. Phase E is then added and thereafter Phase F is sweep mixedtherein for 15 minutes. The so-formed mix is then heated to 75° C. Whilemaintaining the mix at 75° C., Phase G is added. Phase H, heated at 80°C., is then added to the above mix with fast mixing to form an emulsion.The mix is then mixed with moderate speed, cooled to 50° C. and thencombined with Phase I and mixed for 5 minutes. Thereafter Phase J isadded and the mixture is cooled to 30° C. to form the make-up of theinvention. The so-formed make-up of the invention is found to besoothing and noncomedongenic.

EXAMPLE 8 Cosmetic Formulation

A cosmetic formulation in the form of a facial makeup having thefollowing composition is prepared as described below.

    ______________________________________                                        Ingredient              Grams                                                 ______________________________________                                        Deionized water         76                                                    Glycerin                4.5                                                   2-Pyrrolidone-5-carboxylic acid (PCA)                                                                 0.6                                                   Methyl paraben          0.2                                                   Ceraphyl 368 (octyl palmitate)                                                                        3                                                     Silicone 225 (dimethicone)                                                                            1                                                     Tween 60 (Polysorbate 60)                                                                             4.5                                                   Propyl paraben          0.1                                                   Tegin 515 (glyceryl monostearate                                                                      2                                                     40% mono)                                                                     Promulgen D (cetearyl alcohol +                                                                       5.5                                                   ceteareth 20)                                                                 Deionized water         0.5                                                   Dowicil 200 (Quaternium 15)                                                                           0.1                                                   6-Hydroxy-2,5,7,8-tetramethylchroman-                                                                 0.2                                                   2-carboxylic acid (Trolox C-free                                              radical inhibitor)                                                            ______________________________________                                    

Glycerin, 2-pyrrolidone-5-carboxylic acid and methyl paraben are heatedtogether to 70° C. to 75° C. with propeller mixing to form a first mix.

Octyl palmitate, dimethicone, polysorbate 60, propyl paraben, glycerylmonostearate and Promulgen D (cetearyl alcohol and Cetearth 20) areheated together to 70° C. to 75° C. with propeller mixing to form asecond mix.

The second mix is then added to the first mix with propeller mixing andthe mixture is then cooled to 60° C. while sweep mixing. Thereafter,aqueous Dowicil 20 (Quaternium 15) and Trolox C are added at 50° C. andthe mixture is cooled to 30° C. to form the cosmetic of the invention.

EXAMPLE 9 Shampoo Formulation

A shampoo having the following composition is prepared as describedbelow.

    ______________________________________                                        Ingredient              Grams                                                 ______________________________________                                        Deionized water         50                                                    Standapol ES2 (25% sodium laureth                                                                     40                                                    2-sulfate)                                                                    Glydant (55% solution dimethyl                                                                        0.3                                                   dimethoyl hydantoin)                                                          Standapol AB 45% (45% lauryl betaine)                                                                 5                                                     Perfume oil             0.5                                                   Triton X102 (octoxyonol 13)                                                                           2                                                     Methyl paraben          0.1                                                   FDC Red 4 (0.1% solution)                                                                             0.05                                                  85% Phosphoric acid     (qs to pH 6.0)                                        Troxerutin              1                                                     6-Hydroxy-2,5,7,8-tetramethylchroman-                                                                 0.1                                                   2-carboxylic acid (Trolox C-free                                              radical inhibitor)                                                            Potassium hydroxide     0.05                                                  ______________________________________                                    

A first mix is formed by sweep mixing deionized water, Standapol ES2,Glydant and Standapol AB 45% while heating to 60°-65° C. The first mixis cooled to 50° C. and then the Triton X102, Tegin and the FD&C colorare added to the mix with sweep mixing to form a second mix. The pH ofthe second mix is adjusted to 6.0 with phosphoric acid, at 50° C. andthen the troxerutin and Trolox C and KOH are added at 50° C. and the mixis cooled to 30° C. to form the shampoo formulation of the invention.

EXAMPLE 10 Topical Moisturizer Lotion Composition

A topical moisturizer lotion having the following composition isprepared as described below.

    ______________________________________                                                             Parts by Weight                                          ______________________________________                                        Blend I                                                                       Carboxymethyl cellulose                                                                              1                                                      Carbowax 400           2                                                      Deionized water        47                                                     Blend II                                                                      Glydant                0.3                                                    Imidizolidinyl urea    0.2                                                    Deionized water        1                                                      Blend III                                                                     Carbowax 400           10                                                     6-Hydroxy-2,5,7,8-tetramethylchroman-                                                                0.5                                                    2-carboxylic acid (Trolox C-free - radical inhibitor)                         Triethanolamine (99%)  0.3                                                    Blend IV                                                                      Tween 80 (Polysorbate 80)                                                                            2.2                                                    Tween 20 (Polysorbate 20)                                                                            0.6                                                    Blend IV                                                                      Monoethanolamine sulfite                                                                             0.2                                                    (stabilizer for TroIox C)                                                     Deionized water        34.3                                                   ______________________________________                                    

Blend I was formed by premixing the carboxymethyl cellulose and Carbowax400 and adding the water under homomixing while heating at 50° C.

The Blend II ingredients were mixed together and added to Blend I toform Blend I-II.

The Blend III ingredients were stirred at 80° C. until uniform and theresulting Blend III was sweep mixed into Blend I-II to form BlendI-II-III.

Blend IV and V ingredients were then sweep mixed as two separate blendsinto the Blend I-II-III to form the final blend.

The so-formed topical moisturizer lotion of the invention was found tohave excellent moisturizing properties and excellent skin penetratingpower.

In addition, the Trolox C free radical inhibitor was found to bestabilized against decoloration and oxidation by the monoethanolaminesulfite.

What is claimed is:
 1. A skin treatment composition which inhibitsgeneration of or deactivates the free radicals in the skin which freeradicals may form upon exposure of the skin to ultraviolet radiation orair pollutants, in the form of an ointment, cream, lotion, or liquidcomprising water, at least one humectant, at least one thickener, atleast one preservative, from about 0.01 to about 5% by weight of thecomposition of at least one free radical inhibitor or deactivator whichis 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, 6-ethoxy-1,2-dihyro-2,2,4-trimethylquinoline or mixtures thereof, and a stabilizerfor said 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid which ismonoethanolamine sulfite or sodium bisulfite, wherein said stabilizer ispresent in an amount within the range of from about 0.02 to about 0.5%by weight of said composition.
 2. The composition as defined in claim 1wherein the free radical inhibitor or deactivator of Claim 1 is presentin an amount within the range of from about 0.1 to about 0.5% by weightof the composition.
 3. The composition as defined in Claim 1 wherein thefree radical inhibitor or deactivator is6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid.
 4. Thecomposition as defined in claim 1 wherein the free radical inhibitor ordeactivator is 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline.
 5. Thecomposition as defined in claim 1 further including a chelating agentwhich is disodium ethylene diamine tetraacetic acid, tetrasodium EDTA orcitric acid.
 6. The composition as defined in claim 1 in the form of acream, lotion or ointment, wherein the thickener is a cross-linkedacrylic acid polymer and including triethanolamine as a neutralizer forsaid thickener, or said thickener is xanthan gum, magnesium aluminumsilicate, hydroxyethyl cellulose, carboxymethyl cellulose, cetyl alcoholor stearic acid.
 7. The composition as defined in claim 1 wherein thehumectant is propylene glycol, polyethylene glycol, glycerine, sorbitolor butylene glycol.
 8. The composition as defined in claim 1 furtherincluding an emulsifier.
 9. The composition as defined in claim 8wherein the emulsifier is polyethylene glycol 20 sorbitan monolaurate,polyethylene glycol 5 soya sterol, sorbitan tristearate, sorbitantrioleate, glyceryl monopalmitate, diethanolamine cetyl phosphate,glyceryl monostearate, polyethylene glycol 100 stearate, polyethyleneglycol 20 stearyl ether, polyethylene glycol ether of lauryl alcohol,polysorbate 80, lecithin or mixtures thereof.
 10. The composition asdefined in claim 1 further including an emollient.
 11. The compositionas defined in claim 10 wherein the emollient is dimethicone,stearoxydimethicone, diisopropyl dimerate or mineral oil.
 12. Thecomposition as defined in claim 1 wherein the preservative is benzylalcohol, phenoxyethanol, butyl paraben, propylparaben, methyl paraben,imidazolidinyl urea, dimethyldimethoyl hydantoin, or a mixture thereof.13. The composition as defined in claim 1 further including a solventfor the free radical inhibitor or deactivator.
 14. The composition asdefined in claim 1 wherein the solvent is propylene glycol, polyethyleneglycol, ethanol and/or strong base or organic amine for6-hydroxy-2,5,7,8 tetraethylchroman-2-carboxylic acid and vegetable oilor synthetic fatty acid esters for 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline.
 15. The composition as defined in claim 1 wherein the freeradical inhibitor or deactivator is present in an amount within therange of from about 0.1 to about 0.5% by weight and is6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline, the humectant ispolyethylene glycol and propylene glycol, the emulsifier or thickener ispolyethylene glycol 5 soya sterol, polyethylene glycol ether of laurylalcohol, glyceryl monostearate, cetyl alcohol or stearic acid, and thepreservative is benzyl alcohol, methyl paraben, propyl paraben orbutylparaben.
 16. The composition as defined in claim 15 furtherincluding disodium ethylenediamine tetracetic acid as a chelating agent,diisopropyl dimerate, dimethicone and stearoxy dimethicone as anemollient, and polyethylene glycol as a solvent for6hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid.
 17. Thecomposition as defined in claim 1 further including at least one enzymeor modified enzyme.
 18. The composition as defined in claim 1 furtherincluding at least one adjuvant oxygen deactivator.
 19. A skin treatmentcomposition which inhibits generation of or deactivates the freeradicals in the skin which free radicals may form upon exposure of theskin to ultraviolet radiation or air pollutants, in the form of anointment, cream, lotion, or liquid comprising water, at least onehumectant, at least one thickener, at least one preservative, at leastone chelating agent which is disodium ethylene diamine tetraacetic acid,ethylene diamine tetraacetic acid, tetrasodium ethylene diaminetetraacetic acid or citric acid, from about 0.01 to about 5% by weightof the composition of at least one free radical inhibitor or deactivatorwhich is 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid,6-ethoxy-1,2-dihyro-2,2,4-trimethylquinoline or mixtures thereof, and astabilizer for said 6-hydroxy-2,5,7,8-tetramethylchroman2-carboxylicacid which is monoethanolamine sulfite or sodium bisulfite, wherein saidstabilizer is present in an amount within the range of from about 0.02to about 0.5% by weight of said composition.
 20. A skin treatmentcomposition which inhibits generation of or deactivates the freeradicals in the skin which free radicals may form upon exposure of theskin to ultraviolet radiation or air pollutants, in the form of anointment, cream, lotion, or liquid comprising water, at least onehumectant, at least one enzyme or modified enzyme, at least onethickener, at least one preservative, from about 0.01 to about 5% byweight of the composition of at least one free radical inhibitor ordeactivator which is 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylicacid, 6-ethoxy-1,2-dihyro-2,2,4-trimethylquinoline or mixtures thereof,and a stabilizer for said6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid which ismonoethanolamine sulfite or sodium bisulfite, wherein said stabilizer ispresent in an amount within the range of from about 0.02 to about 0.5%by weight of said composition.
 21. The composition as defined in claim20 wherein the enzyme is glycol modified superoxide dismutase orcatalase.
 22. A skin treatment composition comprising6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid in an amount fromabout 0.01 to about 5% by weight of the composition and a stabilizertherefore in an amount from about 0.02 to about 0.5% by weight of saidcomposition, which stabilizer is monoethanolamine sulfite or sodiumbisulfite, said acid being employed in a molar ratio to said stabilizerwithin the range of from about 10:1 to about 0.5:1.
 23. The compositionas defined in claim 22 further including water and an additionalpreservative.
 24. A method for controlling free radical formation onskin which comprises applying to the skin of a mammalian in need of suchtreatment an effective amount of a skin treatment composition in theform of an ointment, cream, lotion or liquid comprising water, fromabout 0.01 to about 5% by weight of a free radical inhibitor ordeactivator which is 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylicacid, 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline, or mixturesthereof, and a stabilizer for said6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid which ismonoethanolamine sulfite or sodium bisulfite, wherein said stabilizer ispresent in an amount within the range of from about 0.02 to about 0.5%by weight of said composition.
 25. A method for inhibiting discolorationor oxidation of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid,which comprises incorporating with said acid a stabilizer therefor whichstabilizer is monoethanolamine sulfite or sodium bisulfite, which isemployed in a molar ratio to said acid of within the range of from about10:1 to about 0.5:1.